Breaking Through Where Cancer Hides
Lumigen Biotech is pioneering antibody-guided nanocomplexes designed to deliver powerful drugs deep within tumors, including those protected by dense tissue and other biological barriers. Our NOVVA™ platform is built to improve tumor-selective drug delivery and reach cancers that remain difficult to treat, creating new possibilities for patients.
Delivering Where Other Treatments Can’t.
Our proprietary NOVVA™ platform is built to break through the barriers that make many cancers, including brain tumors and other aggressive solid tumors, so difficult to treat.
Advancing Treatments of the Future
By pairing proven cancer targets with an advanced antibody-guided nanocomplex platform, Lumigen aims to bring new hope to patients and create lasting value for partners and investors.
Partner with us to bring NOVVA™ therapies to patients worldwide.
